Brief: DMS Group Finalises Clinical Trial Study For Osteoarthritis Treatment
02/03/2020 17:26
March 2 (Reuters) - DIAGNOSTIC MEDICAL SYSTEMS SA
ALHYG.PA :
* FINALIZATION OF PILOT CLINICAL TRIAL STUDY ON THE USE OF
ADIPOSE
TISSUE CELLS IN TREATMENT OF OSTEOARTHRITIS (OA)
Source text: https://bit.ly/3cj31pD
Further company coverage: DMSP.PA
Further company coverage: ALHYG.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587785110;))
Recent news on Aton SA
See all newsBrief: Hybrigenics SA Says Hybrigenics Re-Brands To 'Aton', Commits EUR 15Million To Support Its New Growth And Development Strategy Over Next Three Years
Brief: Hybrigenics 2022 Net Loss EUR 0.5 Million
Brief: Hybrigenics Presents Progress Of B Cell Design Subsidiary
Brief: Hybrigenics Targets EUR 60 Mln Of Turnover By 2025
Brief: Hybrigenics H1 Operating Loss Widens To EUR 0.2 Million